John Deacon

JohnDeacon-Cytosolix

Cytosolix

2018

Affiliations

Yale University

Technologies

Therapeutic

Indication

Oncology

Executive Summary

View/Download

Cytosolix is developing a small-molecule tumor targeted chemotherapy platform.

Newsletter Signup

Corporate Supporters

ABCT is a Program of

An intiative of